Claret’s latest fundraise exceeded its €500 million target, increasing the scale of capital available for growth lending to European companies.
Claret Capital Partners has
closed its fourth European Growth Capital Fund at €575 million, exceeding its
€500 million target. Including affiliated discretionary mandates, the fund will
make growth debt investments in technology, life sciences and impact-focused
companies across Europe.
Claret Capital Partners has closed its fourth growth debt fund at €575M, comprising €440M of Fund IV commitments and €135M of…
European growth debt fund Claret Capital Partners raises €575M, with a third earmarked for biotech, medtech and diagnostics deals.
Fund II will provide €3–15 million in non-dilutive financing to post-Series A technology companies, backed by the EIF, PFR…
Climentum Capital Fund II is targeting €100 million to invest in around 20 early-stage climatetech companies developing…
CVC Capital Partners has closed its third mid-market fund, Catalyst III, at approximately €3 billion, almost double its original…
Europe’s original first-check investor has raised $320M across two funds and expanded its US team to back founders building…
